Crispr Therapeutics shares owned by Clough Capital Partners
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Clough Capital Partners
from 13F filings
Historical chart of Clough Capital Partners investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Clough Capital Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Clough Capital Partners
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $327k | 5.2k | 62.60 |
| 2023-06-30 | $3.2M | 57k | 56.14 |
| 2023-03-31 | $5.5M | 122k | 45.23 |
| 2022-12-31 | $11M | 262k | 40.65 |
| 2022-09-30 | $27M | 415k | 65.35 |
| 2022-06-30 | $19M | 317k | 60.77 |
| 2022-03-31 | $13M | 206k | 62.77 |
| 2021-12-31 | $14M | 187k | 75.78 |
| 2021-09-30 | $16M | 141k | 111.93 |
| 2021-06-30 | $67M | 416k | 161.89 |
| 2021-03-31 | $36M | 296k | 121.85 |
| 2020-12-31 | $22M | 145k | 153.11 |
| 2020-09-30 | $22M | 267k | 83.64 |
| 2020-06-30 | $29M | 394k | 73.49 |
| 2020-03-31 | $21M | 503k | 42.41 |
| 2019-12-31 | $27M | 445k | 60.90 |
| 2019-09-30 | $24M | 574k | 40.99 |
| 2019-06-30 | $28M | 597k | 47.10 |
| 2019-03-31 | $21M | 580k | 35.72 |
| 2018-12-31 | $15M | 516k | 28.57 |
| 2018-09-30 | $15M | 338k | 44.35 |
| 2018-06-30 | $23M | 383k | 58.76 |
| 2018-03-31 | $26M | 560k | 45.71 |
| 2017-12-31 | $21M | 891k | 23.48 |
| 2017-09-30 | $14M | 780k | 17.87 |
| 2017-06-30 | $13M | 797k | 16.02 |
| 2017-03-31 | $18M | 825k | 21.72 |
| 2016-12-31 | $17M | 839k | 19.88 |